U.S. Court of Appeals for the Third Circuit
Fed. Trade Comm'n v. Shire Viropharma, Inc.
This writing
- Type
- Opinion
- Filed
- Feb. 25, 2019
- Case
- Fed. Trade Comm'n v. Shire Viropharma, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
SMITH, Chief Judge. Shire ViroPharma, Inc. ("Shire"), 1 manufactured and marketed the lucrative drug Vancocin, which is indicated to treat a life-threatening gastrointestinal infection. After Shire got wind that manufacturers were considering making generic equivalents to Vancocin, it inundated the United St…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.